Teikyo University · Faculty of Medicine

Research keywordsabscopal effect・immune-related adverse events・esophageal cancer radiotherapy・esophagogastric junction cancer・locally advanced NSCLC・durvalumab after chemoradiotherapy・NY-ESO-1 peptide vaccine・medical image self-supervision

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Identification of the active portion of the CCL3 derivative reported to induce antitumor abscopal effect.
• Fast skin dose estimation system for interventional radiology.
• A phase i study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
• Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: A retrospective study

• 強度変調原体照射法と治療中の同時CT撮影による高精度放射線治療法の開発
• 画像誘導放射線治療を用いたoligometastasesに対する標準治療の確立
• 腫瘍免疫に基づくアブスコパル効果の解明と画期的な放射線治療戦略の開発
• アブスコパル効果のメカニズム解明－腫瘍免疫に基づく画期的腫瘍治療戦略－

• Official profile